Live Analyst Rating Changes 24957 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Shagun Singh Chadha
RBC

Shagun Singh Chadha

RBC Capital
Wall Street Analyst
★★★★☆
#349
on 13Foresight · ranked by our own returns
71%
Success Rate
+3.9%
Average Return
34 of 48 calls profitable · +1.1% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 71% of Shagun Singh Chadha's ratings turned a profit when each position was held for 1 year — averaging +3.9% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

155 Buy 45 Hold 0 Sell
Shagun's Stock Coverage 19 ratings · 2026-08-15
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
EW
Edwards Lifesciences
 Jul 23, 2026 BUY Strong Buy
+9.6% avg upside
34 analysts
$110.00
20.04% Upside
 +9.3% ·
ABT
Abbott Laboratories
 Jul 16, 2026 BUY Strong Buy
+4.3% avg upside
36 analysts
$130.00
16.77% Upside
 +12.6% ·
ISRG
Intuitive Surgical
 Jul 16, 2026 BUY Strong Buy
+21.7% avg upside
36 analysts
$575.00
45.82% Upside
 -1.9% ·
DXCM
Dexcom
 Jul 13, 2026 BUY Strong Buy
+17.8% avg upside
32 analysts
$85.00
5.33% Downside
 +17.5% ·
PODD
Insulet
 Jul 13, 2026 BUY Strong Buy
+51.3% avg upside
32 analysts
$245.00
70.87% Upside
 -17.8% ·
JNJ
Johnson & Johnson
 Jul 13, 2026 BUY Strong Buy
-8.8% avg upside
39 analysts
$287.00
10.16% Upside
 +1.0% ·
MDT
Medtronic
 Jul 13, 2026 BUY Buy
+5.6% avg upside
38 analysts
$118.00
29.30% Upside
 +9.2% ·
SYK
Stryker
 Jul 13, 2026 BUY Strong Buy
+8.8% avg upside
37 analysts
$435.00
28.24% Upside
 +2.9% ·
TFX
Teleflex
 Jul 13, 2026 BUY Buy
+36.6% avg upside
20 analysts
$155.00
13.00% Upside
 +0.8% ·
GMED
Globus Medical
 Jul 13, 2026 BUY Strong Buy
+7.3% avg upside
24 analysts
$115.00
33.91% Upside
 +7.7% ·
TNDM
Tandem Diabetes Care
 Jul 13, 2026 BUY Buy
+44.2% avg upside
29 analysts
$30.00
32.07% Upside
 +39.8% ·
PEN
Penumbra
 Jul 13, 2026 HOLD Buy
+1.0% avg upside
23 analysts
$374.00
14.35% Upside
 +2.5% ·
INSP
Inspire Medical Systems
 Jul 13, 2026 HOLD Buy
+48.0% avg upside
21 analysts
$45.00
21.26% Downside
 +11.2% ·
OM
Outset Medical
 Jul 13, 2026 HOLD Buy
+273.6% avg upside
8 analysts
$7.00
55.25% Upside
 +3.4% ·
GEHC
GE Healthcare Technologies Inc
 Jul 13, 2026 BUY Strong Buy
+11.5% avg upside
22 analysts
$80.00
8.62% Upside
 -5.1% ·
ZBH
Zimmer Biomet Holdings
 Jul 13, 2026 BUY Buy
+13.6% avg upside
38 analysts
$101.00
0.43% Upside
 +4.3% ·
BDX
Becton Dickinson
 Jul 13, 2026 HOLD Buy
+7.1% avg upside
25 analysts
$175.00
4.56% Downside
 +18.3% ·
BSX
Boston Scientific
 Jul 13, 2026 BUY Strong Buy
+30.8% avg upside
38 analysts
$85.00
64.06% Upside
 +15.2% ·
IART
Integra Lifesciences
 Apr 29, 2021 HOLD Buy
+136.8% avg upside
21 analysts
$74.00
303.54% Upside
 -18.5% ·
🔒 14 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Shagun Singh Chadha — Frequently Asked Questions
How accurate are Shagun Singh Chadha's stock ratings?
Based on the calls 13Foresight could measure, about 71% of Shagun's ratings were profitable over a one-year hold, with an average return of +3.9% per rating, or +1.1% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Shagun ranked on 13Foresight?
Shagun Singh Chadha is currently ranked #349 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Shagun cover?
Shagun most recently has ratings on EW, ABT, ISRG, DXCM, PODD, JNJ, MDT, SYK, TFX, GMED, TNDM, PEN and 7 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.